Scorching weather takes its toll on hollywood bowl

Past performance is not a reliable guide to the future. However, investors’ portfolios can benefit from UK shares that have consistently and substantially outperformed the stockmarket. One of the best

Europe has been a winner while US has been a (relative) loser

Drug bust-up: Novo Nordisk is to end its partnership with Hims & Hers Health after less than two months owing to the latter’s sale and promotion of cheap knock-offs of the weight-loss drug Wegovy, say

Stocks are living their best life while the dollar is having its worst year since 1973

Recovery is on the horizon for the running shoes giant under CEO Elliott Hill

London’s Aim market turned 30 this month, but few are celebrating. The 1990s dream of an “accessible” venue to help small UK firms grow has gone largely unrealised, says Richard Evans of Fidelity Inte